Indinavir
From Proteopedia
(Difference between revisions)
| Line 21: | Line 21: | ||
! [[Saquinavir]] | ! [[Saquinavir]] | ||
! [[Amprenavir]] | ! [[Amprenavir]] | ||
| - | ! [[Lopinavir]] | ||
! [[Ritonavir]] | ! [[Ritonavir]] | ||
! [[Darunavir]] | ! [[Darunavir]] | ||
| Line 33: | Line 32: | ||
! Saquinavir | ! Saquinavir | ||
! Amprenavir | ! Amprenavir | ||
| - | ! Lopinavir | ||
! Ritonavir | ! Ritonavir | ||
! Darunavir | ! Darunavir | ||
| Line 45: | Line 43: | ||
! Saquinavir | ! Saquinavir | ||
! Amprenavir | ! Amprenavir | ||
| - | ! Lopinavir | ||
! Ritonavir | ! Ritonavir | ||
! Darunavir | ! Darunavir | ||
| Line 57: | Line 54: | ||
! Saquinavir | ! Saquinavir | ||
! Amprenavir | ! Amprenavir | ||
| - | ! Lopinavir | ||
! Ritonavir | ! Ritonavir | ||
! Darunavir | ! Darunavir | ||
| Line 69: | Line 65: | ||
! Saquinavir | ! Saquinavir | ||
! Amprenavir | ! Amprenavir | ||
| - | ! Lopinavir | ||
! Ritonavir | ! Ritonavir | ||
! Darunavir | ! Darunavir | ||
| Line 81: | Line 76: | ||
! Saquinavir | ! Saquinavir | ||
! Amprenavir | ! Amprenavir | ||
| - | ! Lopinavir | ||
! Ritonavir | ! Ritonavir | ||
! Darunavir | ! Darunavir | ||
| Line 93: | Line 87: | ||
! Saquinavir | ! Saquinavir | ||
! Amprenavir | ! Amprenavir | ||
| - | ! Lopinavir | ||
! Ritonavir | ! Ritonavir | ||
! Darunavir | ! Darunavir | ||
| Line 105: | Line 98: | ||
! Saquinavir | ! Saquinavir | ||
! Amprenavir | ! Amprenavir | ||
| - | ! Lopinavir | ||
! Ritonavir | ! Ritonavir | ||
! Darunavir | ! Darunavir | ||
| Line 117: | Line 109: | ||
! Saquinavir | ! Saquinavir | ||
! Amprenavir | ! Amprenavir | ||
| - | ! Lopinavir | ||
! Ritonavir | ! Ritonavir | ||
! Darunavir | ! Darunavir | ||
| Line 129: | Line 120: | ||
! Saquinavir | ! Saquinavir | ||
! Amprenavir | ! Amprenavir | ||
| - | ! Lopinavir | ||
! Ritonavir | ! Ritonavir | ||
! Darunavir | ! Darunavir | ||
Revision as of 18:56, 1 December 2010
|
Better Known as:
- Marketed By:
- Major Indication: Human Immunodeficiency Virus Infection
- Drug Class: HIV Protease Inhibitor
- Date of FDA Approval (Patent Expiration):
- 2006 Sales:
- Importance:
- The following is a list of Pharmacokinetic Parameters. See: Pharmaceutical Drugs for more information
Mechanism of Action
Pharmacokinetics
| HIV Protease Inhibitor Pharmacokinetics | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Parameter | Ritonavir | Tipranavir | Indinavir | Saquinavir | Amprenavir | Ritonavir | Darunavir | Atazanavir | Nelfinavir | ||
| Tmax (hr) | Ritonavir | Tipranavir | Indinavir | Saquinavir | Amprenavir | Ritonavir | Darunavir | Atazanavir | Nelfinavir | ||
| Cmax (ng/ml) | Ritonavir | Tipranavir | Indinavir | Saquinavir | Amprenavir | Ritonavir | Darunavir | Atazanavir | Nelfinavir | ||
| Bioavailability (%) | Ritonavir | Tipranavir | Indinavir | Saquinavir | Amprenavir | Ritonavir | Darunavir | Atazanavir | Nelfinavir | ||
| Protein Binding (%) | Ritonavir | Tipranavir | Indinavir | Saquinavir | Amprenavir | Ritonavir | Darunavir | Atazanavir | Nelfinavir | ||
| T1/2 (hr) | Ritonavir | Tipranavir | Indinavir | Saquinavir | Amprenavir | Ritonavir | Darunavir | Atazanavir | Nelfinavir | ||
| AUC (ng/ml/hr) | Ritonavir | Tipranavir | Indinavir | Saquinavir | Amprenavir | Ritonavir | Darunavir | Atazanavir | Nelfinavir | ||
| IC50 (nM) | Ritonavir | Tipranavir | Indinavir | Saquinavir | Amprenavir | Ritonavir | Darunavir | Atazanavir | Nelfinavir | ||
| Dosage (mg) | Ritonavir | Tipranavir | Indinavir | Saquinavir | Amprenavir | Ritonavir | Darunavir | Atazanavir | Nelfinavir | ||
| Metabolism | Ritonavir | Tipranavir | Indinavir | Saquinavir | Amprenavir | Ritonavir | Darunavir | Atazanavir | Nelfinavir | ||
References
